rs4788099

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003321.5(TUFM):​c.817+13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 1,613,840 control chromosomes in the GnomAD database, including 116,907 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9544 hom., cov: 32)
Exomes 𝑓: 0.38 ( 107363 hom. )

Consequence

TUFM
NM_003321.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.232

Publications

46 publications found
Variant links:
Genes affected
TUFM (HGNC:12420): (Tu translation elongation factor, mitochondrial) This gene encodes a protein which participates in protein translation in mitochondria. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency resulting in lactic acidosis and fatal encephalopathy. A pseudogene has been identified on chromosome 17. [provided by RefSeq, Jul 2008]
TUFM Gene-Disease associations (from GenCC):
  • combined oxidative phosphorylation defect type 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 16-28844406-A-G is Benign according to our data. Variant chr16-28844406-A-G is described in ClinVar as Benign. ClinVar VariationId is 318747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.398 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUFMNM_003321.5 linkc.817+13T>C intron_variant Intron 6 of 9 ENST00000313511.8 NP_003312.3
TUFMNM_001365360.2 linkc.817+13T>C intron_variant Intron 6 of 9 NP_001352289.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUFMENST00000313511.8 linkc.817+13T>C intron_variant Intron 6 of 9 1 NM_003321.5 ENSP00000322439.3
TUFMENST00000565012.1 linkn.*344+13T>C intron_variant Intron 5 of 6 5 ENSP00000455007.1
TUFMENST00000569217.1 linkn.-74T>C upstream_gene_variant 2
TUFMENST00000561644.1 linkn.*220T>C downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.341
AC:
51857
AN:
151912
Hom.:
9515
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.265
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.406
Gnomad ASJ
AF:
0.268
Gnomad EAS
AF:
0.121
Gnomad SAS
AF:
0.217
Gnomad FIN
AF:
0.424
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.393
Gnomad OTH
AF:
0.305
GnomAD2 exomes
AF:
0.352
AC:
88247
AN:
251028
AF XY:
0.344
show subpopulations
Gnomad AFR exome
AF:
0.271
Gnomad AMR exome
AF:
0.487
Gnomad ASJ exome
AF:
0.274
Gnomad EAS exome
AF:
0.103
Gnomad FIN exome
AF:
0.425
Gnomad NFE exome
AF:
0.388
Gnomad OTH exome
AF:
0.347
GnomAD4 exome
AF:
0.376
AC:
549299
AN:
1461810
Hom.:
107363
Cov.:
66
AF XY:
0.371
AC XY:
269937
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.258
AC:
8625
AN:
33480
American (AMR)
AF:
0.489
AC:
21869
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.270
AC:
7054
AN:
26136
East Asian (EAS)
AF:
0.128
AC:
5069
AN:
39658
South Asian (SAS)
AF:
0.228
AC:
19648
AN:
86258
European-Finnish (FIN)
AF:
0.421
AC:
22495
AN:
53386
Middle Eastern (MID)
AF:
0.206
AC:
1186
AN:
5768
European-Non Finnish (NFE)
AF:
0.398
AC:
442494
AN:
1112006
Other (OTH)
AF:
0.345
AC:
20859
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
23529
47058
70588
94117
117646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13520
27040
40560
54080
67600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.342
AC:
51950
AN:
152030
Hom.:
9544
Cov.:
32
AF XY:
0.340
AC XY:
25261
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.266
AC:
11034
AN:
41458
American (AMR)
AF:
0.407
AC:
6214
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.268
AC:
930
AN:
3470
East Asian (EAS)
AF:
0.121
AC:
626
AN:
5176
South Asian (SAS)
AF:
0.218
AC:
1051
AN:
4830
European-Finnish (FIN)
AF:
0.424
AC:
4477
AN:
10564
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.393
AC:
26677
AN:
67936
Other (OTH)
AF:
0.309
AC:
652
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1728
3456
5183
6911
8639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.363
Hom.:
15161
Bravo
AF:
0.339
Asia WGS
AF:
0.275
AC:
955
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Combined oxidative phosphorylation defect type 4 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.5
DANN
Benign
0.53
PhyloP100
0.23
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4788099; hg19: chr16-28855727; COSMIC: COSV57948579; COSMIC: COSV57948579; API